Public Notices: Peak Powder River Resources, LLC (F031172/A0016113)
Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
04/08/2022 | Press release | Distributed by Public on 04/08/2022 07:11
Please select the service you want to use:
Smartlinks | Sparebank 68 Grader Nord | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Financial Services | Banking | Public Companies | Banks | Euronext Oslo
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact